Gate Bioscience

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$60M

Gate Bioscience is a biotechnology company that has developed a scientific platform to create Molecular Gates, small molecules that target and eliminate disease-causing extracellular proteins, and has raised $60M in a Series A funding round to advance its proprietary Molecular Gate Discovery Platform.